In the past decade, advanced lung cancer and melanoma have witnessed a surge in Food and Drug Administration (FDA)–approved treatment innovations. Yet, the impact of these advancements on ...

Among patients with metastatic lung cancer and melanoma, for whom the lifetime incidence of brain metastases is up to 40% and 80%, respectively, brain imaging surveillance has been adopted into ...

To advance the call to action to optimize dosage of anticancer agents, FDA and ASCO cosponsored two multistakeholder workshops, Getting the Dose Right: Optimizing Dose Selection Strategies in Oncology ...

The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...

PURPOSEThere are limited data on the risk for mortality and health outcomes among the increasing population of older (age >50 years) survivors of childhood cancer during this later stage in life ...

In the article that accompanies this editorial, Dr Zhang et al 7 report on a randomized controlled trial in which patients with cT1N0 invasive adenocarcinoma with a consolidation-to-tumor ratio ≤0.5 ...

Pancreatic cancer is one of the most lethal cancers in the United States. Many patients with pancreatic cancer ultimately require end-of-life (EOL) care, which encompasses various aspects, including ...

Bladder cancer (BLCA) ranks as the tenth most common malignancy worldwide, with rising incidence and mortality rates. Owing to its molecular and clinical heterogeneity, BLCA is associated with high ...

It was a typical morning in the oncology outpatient clinic. The day was unfolding with its usual cadence. Charts were flipped, the air buzzed with protocol adjustments, and cycles were discussed with ...

PURPOSEWe conducted a phase II, multicenter trial (ClinicalTrials.gov identifier: NCT03427866) investigating ruxolitinib administration before, during, and after allogeneic hematopoietic cell ...

This study investigates the incidence and clinicopathologic characteristics of head and neck cancer (HNC) in the Surinamese population, with an emphasis on the burden of human papillomavirus (HPV) and ...

The objective was to identify factors associated with self-reported symptom burden measured using Symptom Screening in Pediatrics Tool (SSPedi) in pediatric patients with cancer.